Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Hot on Facebook

'Serpent Pastor' Dies of Snake Bite Mack Wolford believed faith compelled him to face the risk »

Drug Giants Target Cancer

Scientific advances, potentially huge profits attract Big Pharma to cancer fight

By Rob Quinn, Newser Staff

Posted Sep 2, 2009 2:16 AM CDT

(Newser) – Major drug companies are tying their fortunes to cancer like never before, the New York Times reports. The firms—inspired by advancements in science as well as the high prices cancer drugs command—are pouring unprecedented resources into the search for new cancer drugs. The... Read full story »

COMMENTS

Read the comment policy

You need to Log in to Newser to comment. Don't have an account yet? Sign up now!

4 comments

A snapshot of the day's best news stories.

View Larger Grid

All Today Yesterday Pick a Date

What's Popular Now on Facebook

'Serpent Pastor' Dies of Snake Bite

Miami Face-Eater Identified

New York Times (Source Grid »)

Money • Health

cancer • pharmaceutical companies • drug companies • Pfizer • cancer research • prescription drugs • pharmaceutical industry • cancer drug

More Newser Stories

Disgraced Doctors Land at Big Pharma

Hundreds of pitchmen found to have blemished records

(NEWSER) - Pharmaceutical companies say they hire highly respected doctors as their white-coat sales force, peddling their drugs to other physicians. But a Pro Publica investigation has discovered that hundreds of these pitchmen have been accused of professional misconduct, been disciplined by state boards, or lacked credentials. Medical board records in the 15 most populous states revealed that more than 250 had been sanctioned, another 40 given FDA warnings for research lapses, and 20 more hit with successful malpractice lawsuits. Some have even lost their licenses. More»

Drugmakers Hike Prices Ahead of Reform

9% rise, in a year of falling prices, will add $10B to drug spending

(NEWSER) - Bracing for health care reform, drug companies have been raising prices at the fastest rate in almost 20 years—even as they pledge to support Washington's goal of cutting the nation's drug bill. The pharmaceutical industry is scrambling to get the price base as high as possible before legislation to curb drug spending kicks in, critics tell the New York Times . More»

Pfizer in Talks to Buy Wyeth

Sources say drug maker plans $60B acquisition of rival Wyeth

(NEWSER) - Pfizer is seeking to create a Big Pharma behemoth with the acquisition of rival Wyeth, insiders tell the Wall Street Journal. The deal, expected to be worth around $60 billion, would make Pfizer—already the world's biggest drug company—big enough to redraw the map of the industry, although sources say the state of the economy means the talks could still collapse. More»

Pfizer to Can 800 Researchers

Company must cut R&D spending ahead of Lipitor patent expiration

(NEWSER) - Pfizer will eliminate the jobs of up to 800 researchers in 2009, starting today, the Wall Street Journal reports. The pharmaceutical giant is attempting to cut costs ahead of a $30 billion reduction in revenue expected in 2011 when its patent on the popular cholesterol drug Lipitor expires. But the cuts signal a larger rethinking of pharmaceutical R&D. More»

Dangerous Counterfeit Cancer Drug Found in US

Fake Avastin missing active ingredient

(NEWSER) - A fake version of best-selling anti-cancer drug Avastin has been found in the US. Swiss drugmaker Roche has warned doctors and hospitals to be on the lookout for the counterfeit medication, which lacks the intravenous drug's active ingredient, the Wall Street Journal reports. Samples of the fake drug are still being analyzed, but "it's not Avastin, it's not safe and effective, and it shouldn't be used," warns a company spokeswoman. More»

NEWS FROM OUR PARTNERS

What is Newser?

Face it: there's too much news. At Newser, we choose the most thought-provoking and entertaining stories from hundreds of US and international sources and reduce them to a headline, picture, and two paragraphs. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »

Partnering with: Slate

View Newser on the mobile website

Drug Giants Target Cancer

Scientific advances, potentially huge profits attract Big Pharma to cancer fight

cancer • pharmaceutical companies • drug companies • Pfizer • cancer research • prescription drugs • pharmaceutical industry • cancer drug

MOST POPULAR STORIES

[ By Views ]

[ By Comments ]

More Newser Stories

Disgraced Doctors Land at Big Pharma

Hundreds of pitchmen found to have blemished records

Drugmakers Hike Prices Ahead of Reform

9% rise, in a year of falling prices, will add $10B to drug spending

Pfizer in Talks to Buy Wyeth

Sources say drug maker plans $60B acquisition of rival Wyeth

Pfizer to Can 800 Researchers

Company must cut R&D spending ahead of Lipitor patent expiration

Dangerous Counterfeit Cancer Drug Found in US

Fake Avastin missing active ingredient

About Us

Site

Community

Site Maps

Tools

More News

What is Newser?